BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 24945093)

  • 1. Innate immune cell-produced IL-17 sustains inflammation in bullous pemphigoid.
    Le Jan S; Plée J; Vallerand D; Dupont A; Delanez E; Durlach A; Jackson PL; Edwin Blalock J; Bernard P; Antonicelli F
    J Invest Dermatol; 2014 Dec; 134(12):2908-2917. PubMed ID: 24945093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid.
    Verraes S; Hornebeck W; Polette M; Borradori L; Bernard P
    J Invest Dermatol; 2001 Nov; 117(5):1091-6. PubMed ID: 11710917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-23/IL-17 Axis Activates IL-1β-Associated Inflammasome in Macrophages and Generates an Auto-Inflammatory Response in a Subgroup of Patients With Bullous Pemphigoid.
    Le Jan S; Muller C; Plee J; Durlach A; Bernard P; Antonicelli F
    Front Immunol; 2019; 10():1972. PubMed ID: 31507596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct compartmentalization of immune cells and mediators characterizes bullous pemphigoid disease.
    Margaroli C; Bradley B; Thompson C; Brown MR; Giacalone VD; Bhatt L; Stoff B; Ahuja S; Springman E; Tirouvanziam R; Feldman RJ
    Exp Dermatol; 2020 Dec; 29(12):1191-1198. PubMed ID: 33047366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bullous pemphigoid outcome is associated with CXCL10-induced matrix metalloproteinase 9 secretion from monocytes and neutrophils but not lymphocytes.
    Riani M; Le Jan S; Plée J; Durlach A; Le Naour R; Haegeman G; Bernard P; Antonicelli F
    J Allergy Clin Immunol; 2017 Mar; 139(3):863-872.e3. PubMed ID: 27637385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a role of eosinophils in blister formation in bullous pemphigoid.
    de Graauw E; Sitaru C; Horn M; Borradori L; Yousefi S; Simon HU; Simon D
    Allergy; 2017 Jul; 72(7):1105-1113. PubMed ID: 28135772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil extracellular traps contribute to immune dysregulation in bullous pemphigoid via inducing B-cell differentiation and antibody production.
    Fang H; Shao S; Xue K; Yuan X; Qiao P; Zhang J; Cao T; Luo Y; Bai X; Li W; Li C; Qiao H; Dang E; Wang G
    FASEB J; 2021 Jul; 35(7):e21746. PubMed ID: 34151465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proinflammatory role of blister fluid-derived exosomes in bullous pemphigoid.
    Fang H; Shao S; Jiang M; Dang E; Shen S; Zhang J; Qiao P; Li C; Wang G
    J Pathol; 2018 May; 245(1):114-125. PubMed ID: 29468680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins.
    Borrego L; Maynard B; Peterson EA; George T; Iglesias L; Peters MS; Newman W; Gleich GJ; Leiferman KM
    Am J Pathol; 1996 Mar; 148(3):897-909. PubMed ID: 8774144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NET Formation in Bullous Pemphigoid Patients With Relapse Is Modulated by IL-17 and IL-23 Interplay.
    Giusti D; Bini E; Terryn C; Didier K; Le Jan S; Gatouillat G; Durlach A; Nesmond S; Muller C; Bernard P; Antonicelli F; Pham BN
    Front Immunol; 2019; 10():701. PubMed ID: 31019514
    [No Abstract]   [Full Text] [Related]  

  • 11. Monocytes enhance neutrophil-induced blister formation in an ex vivo model of bullous pemphigoid.
    de Graauw E; Sitaru C; Horn MP; Borradori L; Yousefi S; Simon D; Simon HU
    Allergy; 2018 May; 73(5):1119-1130. PubMed ID: 29222810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of IL-1 alpha, IL-1 beta and IL-1 receptor antagonist in blister fluid of bullous pemphigoid.
    Schmidt E; Mittnacht A; Schömig H; Dummer R; Bröcker EB; Zillikens D
    J Dermatol Sci; 1996 Feb; 11(2):142-7. PubMed ID: 8869035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Activity and Apoptosis of Eosinophils in Blister Fluids, Skin and Peripheral Blood of Patients with Bullous Pemphigoid.
    Engmann J; Rüdrich U; Behrens G; Papakonstantinou E; Gehring M; Kapp A; Raap U
    Acta Derm Venereol; 2017 Apr; 97(4):464-471. PubMed ID: 27868136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid.
    Schmidt E; Bastian B; Dummer R; Tony HP; Bröcker EB; Zillikens D
    Arch Dermatol Res; 1996 Jun; 288(7):353-7. PubMed ID: 8818181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers related to bullous pemphigoid activity and outcome.
    Giusti D; Le Jan S; Gatouillat G; Bernard P; Pham BN; Antonicelli F
    Exp Dermatol; 2017 Dec; 26(12):1240-1247. PubMed ID: 29105148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-17 expression in dermatitis herpetiformis and bullous pemphigoid.
    Zebrowska A; Wagrowska-Danilewicz M; Danilewicz M; Stasikowska-Kanicka O; Cynkier A; Sysa-Jedrzejowska A; Waszczykowska E
    Mediators Inflamm; 2013; 2013():967987. PubMed ID: 23970818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JID VisualDx quiz: December 2014.
    Shabbir A; Kirsner RS
    J Invest Dermatol; 2014 Dec; 134(12):1-2. PubMed ID: 25381771
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased expression of NLRP3 inflammasome components and interleukin-18 in patients with bullous pemphigoid.
    Fang H; Shao S; Cao T; Lei J; Dang E; Zhang J; Wang G
    J Dermatol Sci; 2016 Aug; 83(2):116-23. PubMed ID: 27174093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High level of thymus and activation-regulated chemokine in blister fluid and sera of patients with bullous pemphigoid.
    Kakinuma T; Wakugawa M; Nakamura K; Hino H; Matsushima K; Tamaki K
    Br J Dermatol; 2003 Feb; 148(2):203-10. PubMed ID: 12588369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin-homing interleukin-4 and -13-producing cells contribute to bullous pemphigoid: remission of disease is associated with increased frequency of interleukin-10-producing cells.
    Teraki Y; Hotta T; Shiohara T
    J Invest Dermatol; 2001 Nov; 117(5):1097-102. PubMed ID: 11710918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.